| Year |
Citation |
Score |
| 2021 |
Abril YLN, Fernandez IR, Hong JY, Chiang YL, Kutateladze DA, Zhao Q, Yang M, Hu J, Sadhukhan S, Li B, He B, Remick B, Bai JJ, Mullmann J, Wang F, et al. Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer. Oncogene. PMID 33479498 DOI: 10.1038/s41388-020-01637-w |
0.471 |
|
| 2019 |
Li M, Chiang YL, Lyssiotis CA, Teater MR, Hong JY, Shen H, Wang L, Hu J, Jing H, Chen Z, Jain N, Duy C, Mistry SJ, Cerchietti L, Cross JR, et al. Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis. Cancer Cell. 35: 916-931.e9. PMID 31185214 DOI: 10.1016/J.Ccell.2019.05.002 |
0.45 |
|
| 2016 |
Jing H, Hu J, He B, Negrón Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang YL, Southard T, Giannakakou P, Weiss RS, Lin H. A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity. Cancer Cell. 29: 767-768. PMID 27165747 DOI: 10.1016/J.Ccell.2016.04.005 |
0.484 |
|
| 2016 |
Jing H, Hu J, He B, Negrón Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang YL, Southard T, Giannakakou P, Weiss RS, Lin H. A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity. Cancer Cell. 29: 607. PMID 27070708 DOI: 10.1016/j.ccell.2016.03.011 |
0.463 |
|
| 2016 |
Jing H, Hu J, He B, Negrón Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang YL, Southard T, Giannakakou P, Weiss RS, Lin H. A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity. Cancer Cell. 29: 297-310. PMID 26977881 DOI: 10.1016/j.ccell.2016.02.007 |
0.484 |
|
| 2016 |
Chiang YL, Lin H. An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3. Organic & Biomolecular Chemistry. PMID 26796034 DOI: 10.1039/C5Ob02609A |
0.447 |
|
| 2015 |
Yang C, Lo WL, Kuo YH, Sang JC, Lee CY, Chiang YW, Chen RP. Revealing structural changes of prion protein during conversion from α-helical monomer to β-oligomers by means of ESR and nanochannel encapsulation. Acs Chemical Biology. 10: 493-501. PMID 25375095 DOI: 10.1021/Cb500765E |
0.316 |
|
| 2012 |
Gerfaud T, Chiang YL, Kreituss I, Russak JA, Bode JW. Enantioselective, chromatography-free synthesis of β 3-Amino acids with natural and unnatural side chains Organic Process Research and Development. 16: 687-696. DOI: 10.1021/Op300069N |
0.591 |
|
| 2012 |
Chiang YL, Russak JA, Carrillo N, Bode JW. Synthesis of enantiomerically pure isoxazolidine monomers for the preparation of β3-oligopeptides by iterative α-keto acidhydroxylamine (KAHA) ligations Helvetica Chimica Acta. 95: 2481-2501. DOI: 10.1002/Hlca.201200484 |
0.591 |
|
| 2006 |
Shie TH, Chiang YL, Lin JJ, Li YK, Lo LC. Facile synthesis toward the construction of an activity probe library for glycosidases. Carbohydrate Research. 341: 443-56. PMID 16414035 DOI: 10.1016/j.carres.2005.12.005 |
0.417 |
|
| 2005 |
Lo LC, Chiang YL, Kuo CH, Liao HK, Chen YJ, Lin JJ. Study of the preferred modification sites of the quinone methide intermediate resulting from the latent trapping device of the activity probes for hydrolases. Biochemical and Biophysical Research Communications. 326: 30-5. PMID 15567148 DOI: 10.1016/J.Bbrc.2004.11.003 |
0.429 |
|
| 2002 |
Lo LC, Pang TL, Kuo CH, Chiang YL, Wang HY, Lin JJ. Design and synthesis of class-selective activity probes for protein tyrosine phosphatases. Journal of Proteome Research. 1: 35-40. PMID 12643524 DOI: 10.1021/Pr015506A |
0.417 |
|
| Show low-probability matches. |